Cargando…
Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions
Glioblastoma multiforme (GBM), the most common form of primary malignant brain cancer in adults, is a devastating disease for which effective treatment has remained elusive for over 75 years. One reason for the minimal progress during this time is the lack of accurate preclinical models to represent...
Autores principales: | Gilbert, Ashley N., Anderson, Joshua C., Duarte, Christine W., Shevin, Rachael S., Langford, Catherine P., Singh, Raj, Gillespie, G. Yancey, Willey, Christopher D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976646/ https://www.ncbi.nlm.nih.gov/pubmed/29849102 http://dx.doi.org/10.1038/s41598-018-26840-4 |
Ejemplares similares
-
A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
por: Stackhouse, Christian T., et al.
Publicado: (2019) -
Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential
por: Stackhouse, Christian T., et al.
Publicado: (2020) -
Functional profiling of microtumors to identify cancer associated fibroblast-derived drug targets
por: Horman, Shane R., et al.
Publicado: (2017) -
A human vascularized microtumor model of patient-derived colorectal cancer recapitulates clinical disease
por: Hachey, Stephanie J., et al.
Publicado: (2023) -
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer
por: Anderle, Nicole, et al.
Publicado: (2022)